Literature DB >> 19659411

Tele-education on leprosy: evaluation of an educational strategy.

Maurício Pedreira Paixão1, Hélio Amante Miot, Chao Lung Wen.   

Abstract

The purpose of this research was to evaluate educational strategies applied to a tele-education leprosy course. The curriculum was for members of the Brazilian Family Health Team and was made available through the Sao Paulo Telehealth Portal. The course educational strategy was based on a constructivist learning model where interactivity was emphasized. Authors assessed motivational aspects of the course using the WebMAC Professional tool. Forty-eight healthcare professionals answered the evaluation questionnaire. Adequate internal consistency was achieved (Cronbach's alpha = 0.79). More than 95% of queried items received good evaluations. Multidimensional analysis according to motivational groups of questions (STIMULATING, MEANINGFUL, ORGANIZED, EASY-TO-USE) showed high agreement. According to WebMAC's criteria, it was considered an "awesome course." The tele-educational strategies implemented for leprosy disclosed high motivational scores.

Mesh:

Year:  2009        PMID: 19659411     DOI: 10.1089/tmj.2008.0137

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  2 in total

1.  Telegenetics: application of a tele-education program in genetic syndromes for Brazilian students.

Authors:  Luciana Paula Maximino; Mirela Machado Picolini-Pereira; José Luiz Brito Carvalho
Journal:  J Appl Oral Sci       Date:  2014 Nov-Dec       Impact factor: 2.698

2.  Medical Doctors' Offline Computer-Assisted Digital Education: Systematic Review by the Digital Health Education Collaboration.

Authors:  Hayfaa Abdelmageed Wahabi; Samia Ahmed Esmaeil; Khawater Hassan Bahkali; Maher Abdelraheim Titi; Yasser Sami Amer; Amel Ahmed Fayed; Amr Jamal; Nasriah Zakaria; Amna Rehana Siddiqui; Monika Semwal; Lorainne Tudor Car; Paul Posadzki; Josip Car
Journal:  J Med Internet Res       Date:  2019-03-01       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.